Dafna D Gladman (D D Gladman, Dafna Gladman)

ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 172

Top Venues

The Journal of rheumatology

Annals of the rheumatic diseases

RMD open

Rheumatology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Megan R W Barber, Manuel Francisco Ugarte-Gil, John G Hanly, Murray B Urowitz, Yvan St-Pierre, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Sasha Bernatsky, Daniel J Wallace, David Alan Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle A Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Ronald F Van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, S Sam Lim, Murat Inanç, Kenneth C Kalunian, Søren Jacobsen, Christine A Peschken, Diane L Kamen, Anca Askanase, Bernardo A Pons-Estel, Francesca S Cardwell, Graciela S Alarcon, Ann Elaine Clarke
Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. Annals of the rheumatic diseases (2024)
Eric F Morand, Joseph F Merola, Yoshiya Tanaka, Dafna D Gladman, Roy M Fleischmann
TYK2: an emerging therapeutic target in rheumatic disease. Nature reviews. Rheumatology 20 (4) (2024)
Eric F Morand, Joseph F Merola, Yoshiya Tanaka, Dafna D Gladman, Roy M Fleischmann
TYK2: an emerging therapeutic target in rheumatic disease. Nature reviews. Rheumatology 20 (4) (2024)
Laure Gossec, Ana Maria Orbai, Laura C Coates, Dafna D Gladman, Philip S Helliwell, Christopher G Pelligra, Valérie Ciaravino, Barbara Ink, Vanessa Taieb, Jérémy Lambert, Maarten P T de Wit
Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis. RMD open 10 (1) (2024)
Gizem Ayan, Sibel Zehra Aydın, Laura C Coates, Lihi Eder, Dafna D Gladman, Philip S Helliwell, Gurjit S Kaeley, Arthur Kavanaugh, Phillip J Mease, Stephen R Pennington, Fabian Proft, Enrique Roberto Soriano, Oliver M FitzGerald
GRAPPA 2023: Major Projects, Key Advances, and Milestones. The Journal of rheumatology (2024)
Oliver M FitzGerald, Dafna D Gladman, Phillip J Mease, Christopher T Ritchlin, Josef S Smolen, Lu Gao, Yanhua Hu, Miroslawa Nowak, Subhashis Banerjee, Ian Catlett
Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Biomarkers Associated With Disease Activity, Pharmacodynamics, and Clinical Responses. Arthritis & rheumatology (Hoboken, N.J.) 76 (9) (2024)
Jeffrey R Curtis, Iain B McInnes, Proton Rahman, Dafna D Gladman, Steven Peterson, Feifei Yang, Oluwakayode Adejoro, Alexa P Kollmeier, Natalie J Shiff, Chenglong Han, May Shawi, William Tillett, Phillip J Mease
Work Productivity and General Health Through 2 Years of Guselkumab Treatment in a Phase 3 Randomized Trial of Patients With Active Psoriatic Arthritis. Rheumatology and therapy 11 (2) (2024)
Vinod Chandran, Louis Bessette, J Carter Throne, Maqbool Sheriff, Proton Rahman, Dafna D Gladman, Sabeen Anwar, Jennifer Jelley, Anne-Julie Gaudreau, Manprit Chohan, John S Sampalis
Use of Apremilast to Achieve Psoriatic Arthritis Treatment Goals and Satisfaction at 1 Year in the Canadian Real-World APPRAISE Study. Rheumatology and therapy (2024)
Vinod Chandran, Louis Bessette, J Carter Throne, Maqbool Sheriff, Proton Rahman, Dafna D Gladman, Sabeen Anwar, Jennifer Jelley, Anne-Julie Gaudreau, Manprit Chohan, John S Sampalis
Use of Apremilast to Achieve Psoriatic Arthritis Treatment Goals and Satisfaction at 1 Year in the Canadian Real-World APPRAISE Study. Rheumatology and therapy 11 (2) (2024)
Lars Erik Kristensen, Atul A Deodhar, Ying Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D Kinch, Dafna D Gladman
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data. Rheumatology and therapy (2024)
Laura C Coates, Robert B M Landewe, Iain B McInnes, Phillip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Joseph F Merola
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL. RMD open 10 (1) (2024)
Laura C Coates, Robert B M Landewe, Iain B McInnes, Phillip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Joseph F Merola
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL. RMD open 10 (1) (2024)
Jeffrey R Curtis, Iain B McInnes, Proton Rahman, Dafna D Gladman, Steven Peterson, Feifei Yang, Oluwakayode Adejoro, Alexa P Kollmeier, Natalie J Shiff, Chenglong Han, May Shawi, William Tillett, Phillip J Mease
Work Productivity and General Health Through 2 Years of Guselkumab Treatment in a Phase 3 Randomized Trial of Patients With Active Psoriatic Arthritis. Rheumatology and therapy 11 (2) (2024)
Vinod Chandran, Louis Bessette, J Carter Throne, Maqbool Sheriff, Proton Rahman, Dafna D Gladman, Sabeen Anwar, Jennifer Jelley, Anne-Julie Gaudreau, Manprit Chohan, John S Sampalis
Use of Apremilast to Achieve Psoriatic Arthritis Treatment Goals and Satisfaction at 1 Year in the Canadian Real-World APPRAISE Study. Rheumatology and therapy 11 (2) (2024)
Oliver M FitzGerald, Dafna D Gladman, Phillip J Mease, Christopher T Ritchlin, Josef S Smolen, Lu Gao, Yanhua Hu, Miroslawa Nowak, Subhashis Banerjee, Ian Catlett
Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Biomarkers Associated With Disease Activity, Pharmacodynamics, and Clinical Responses. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Eric F Morand, Joseph F Merola, Yoshiya Tanaka, Dafna D Gladman, Roy M Fleischmann
TYK2: an emerging therapeutic target in rheumatic disease. Nature reviews. Rheumatology (2024)
Xenofon Baraliakos, Dafna D Gladman, Soumya D Chakravarty, Cinty Gong, May Shawi, Emmanouil Rampakakis, Kishimoto Mitsumasa, Enrique Roberto Soriano, Phillip J Mease
BASDAI versus ASDAS in evaluating axial involvement in patients with psoriatic arthritis: a pooled analysis of two phase 3 studies. Rheumatology advances in practice 8 (2) (2024)
Lars Erik Kristensen, Atul A Deodhar, Ying Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D Kinch, Dafna D Gladman
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data. Rheumatology and therapy 11 (3) (2024)
Lars Erik Kristensen, Atul A Deodhar, Ying Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D Kinch, Dafna D Gladman
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data. Rheumatology and therapy 11 (3) (2024)
Laura C Coates, Robert B M Landewe, Iain B McInnes, Phillip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Joseph F Merola
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL. RMD open 10 (1) (2024)
Dafna D Gladman, Oliver M FitzGerald, April W Armstrong, Niti Goel, Alice B Gottlieb
Prologue: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2023 Annual Meeting. The Journal of rheumatology (2024)
Jeffrey R Curtis, Iain B McInnes, Proton Rahman, Dafna D Gladman, Steven Peterson, Feifei Yang, Oluwakayode Adejoro, Alexa P Kollmeier, Natalie J Shiff, Chenglong Han, May Shawi, William Tillett, Phillip J Mease
Work Productivity and General Health Through 2 Years of Guselkumab Treatment in a Phase 3 Randomized Trial of Patients With Active Psoriatic Arthritis. Rheumatology and therapy 11 (2) (2024)
Lars Erik Kristensen, Atul A Deodhar, Ying Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D Kinch, Dafna D Gladman
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data. Rheumatology and therapy 11 (3) (2024)
Oliver FitzGerald, Dafna D Gladman, Phillip J Mease, Christopher T Ritchlin, Josef S Smolen, Lu Gao, Yanhua Hu, Miroslawa Nowak, Subhashis Banerjee, Ian Catlett
Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Biomarkers Associated With Disease Activity, Pharmacodynamics, and Clinical Responses. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Vinod Chandran, Louis Bessette, J Carter Throne, Maqbool Sheriff, Proton Rahman, Dafna D Gladman, Sabeen Anwar, Jennifer Jelley, Anne-Julie Gaudreau, Manprit Chohan, John S Sampalis
Use of Apremilast to Achieve Psoriatic Arthritis Treatment Goals and Satisfaction at 1 Year in the Canadian Real-World APPRAISE Study. Rheumatology and therapy 11 (2) (2024)
Laure Gossec, Ana Maria Orbai, Laura C Coates, Dafna D Gladman, Philip S Helliwell, Christopher G Pelligra, Valérie Ciaravino, Barbara Ink, Vanessa Taieb, Jérémy Lambert, Maarten P T de Wit
Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis. RMD open 10 (1) (2024)
Lars Erik Kristensen, Atul A Deodhar, Ying Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D Kinch, Dafna D Gladman
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data. Rheumatology and therapy 11 (3) (2024)
Laura C Coates, Robert B M Landewe, Iain B McInnes, Phillip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Joseph F Merola
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL. RMD open 10 (1) (2024)
Dafna D Gladman, Vinod Chandran, Cheryl F Rosen, Sherry Rohekar, Tristan A Boyd, Lihi Eder, Proton Rahman, Jan P Dutz, Jonathan Chan, Richard P Haydey, Snezana Barac, Marie-Claude Laliberté, Tanya Girard, Pierre-André Fournier, Mitchell Sutton, Daniel Pereira, Tina Chim, Louis Coupal, Denis Choquette
Residual Disease Activity in Canadian Patients With Psoriatic Arthritis Treated With Advanced Therapies: Results From a Multiregistry Analysis (UNISON-PsA). The Journal of rheumatology 51 (5) (2024)
Xenofon Baraliakos, Dafna D Gladman, Soumya D Chakravarty, Cinty Gong, May Shawi, Emmanouil Rampakakis, Kishimoto Mitsumasa, Enrique Roberto Soriano, Phillip J Mease
BASDAI versus ASDAS in evaluating axial involvement in patients with psoriatic arthritis: a pooled analysis of two phase 3 studies. Rheumatology advances in practice 8 (2) (2024)
Laure Gossec, Ana Maria Orbai, Laura C Coates, Dafna D Gladman, Philip S Helliwell, Christopher G Pelligra, Valérie Ciaravino, Barbara Ink, Vanessa Taieb, Jérémy Lambert, Maarten P T de Wit
Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis. RMD open 10 (1) (2024)
Eric F Morand, Joseph F Merola, Yoshiya Tanaka, Dafna D Gladman, Roy M Fleischmann
TYK2: an emerging therapeutic target in rheumatic disease. Nature reviews. Rheumatology (2024)
Vinod Chandran, Dafna D Gladman, Phillip J Mease, Lihi Eder, Stephen R Pennington, Oliver M FitzGerald, Christopher T Ritchlin, Dan E Webster, Kurt de Vlam, Wilson Liao
GRAPPA 2023 Collaborative Research Network Meeting. The Journal of rheumatology (2024)
Laure Gossec, Laura C Coates, Dafna D Gladman, Jacob A Aelion, Jitendra Vasandani, Andreas Pinter, Joseph F Merola, Arthur Kavanaugh, Jyotsna Reddy, Rebecca Wang, Michele Brunori, Yuri Klyachkin, Cynthia Deignan, Phillip J Mease
Treatment of early oligoarticular psoriatic arthritis with apremilast: primary outcomes at week 16 from the FOREMOST randomised controlled trial. Annals of the rheumatic diseases (2024)
Jeffrey R Curtis, Iain B McInnes, Proton Rahman, Dafna D Gladman, Steven Peterson, Feifei Yang, Oluwakayode Adejoro, Alexa P Kollmeier, Natalie J Shiff, Chenglong Han, May Shawi, William Tillett, Phillip J Mease
Work Productivity and General Health Through 2 Years of Guselkumab Treatment in a Phase 3 Randomized Trial of Patients With Active Psoriatic Arthritis. Rheumatology and therapy (2024)
Dafna D Gladman, Vinod Chandran, Cheryl F Rosen, Sherry Rohekar, Tristan A Boyd, Lihi Eder, Proton Rahman, Jan P Dutz, Jonathan Chan, Richard P Haydey, Snezana Barac, Marie-Claude Laliberté, Tanya Girard, Pierre-André Fournier, Mitchell Sutton, Daniel Pereira, Tina Chim, Louis Coupal, Denis Choquette
Residual Disease Activity in Canadian Patients With Psoriatic Arthritis Treated With Advanced Therapies: Results From a Multiregistry Analysis (UNISON-PsA). The Journal of rheumatology 51 (5) (2024)
Eric F Morand, Joseph F Merola, Yoshiya Tanaka, Dafna D Gladman, Roy M Fleischmann
TYK2: an emerging therapeutic target in rheumatic disease. Nature reviews. Rheumatology 20 (4) (2024)
Dafna D Gladman, Philip S Helliwell, Phillip J Mease
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Celebrates Its 20th Anniversary. The Journal of rheumatology (2024)
Sherry Rohekar, Jordi Pardo Pardo, Reza Mirza, Sibel Zehra Aydın, Louis Bessette, Nicolas Richard, Dianne Mosher, Tristan A Boyd, Jonathan Chan, Lihi Eder, Laura Passalent, Elie Karam, Bindu Nair, Glen Stewart Hazlewood, Shirley M L Tse, Dax Rumsey, Michel Zummer, Nigil Haroon, Robert Davies Inman, Dafna D Gladman
Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial Spondyloarthritis. The Journal of rheumatology (2024)
Ying Ying Leung, Dafna D Gladman, Ana Maria Orbai, William Tillett
Composite Outcome Measures for Psoriatic Arthritis: OMERACT and 3 and 4 Visual Analog Scale Progress in 2023. The Journal of rheumatology (2024)
Laure Gossec, Ana Maria Orbai, Laura C Coates, Dafna D Gladman, Philip S Helliwell, Christopher G Pelligra, Valérie Ciaravino, Barbara Ink, Vanessa Taieb, Jérémy Lambert, Maarten P T de Wit
Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis. RMD open 10 (1) (2024)
Laura C Coates, Robert B M Landewe, Iain B McInnes, Phillip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Joseph F Merola
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL. RMD open 10 (1) (2024)
Joo-Young E Lee, Arielle Mendel, Anca D Askanase, Sang-Cheol Bae, Jill P Buyon, Ann Elaine Clarke, Nathalie Costedoat-Chalumeau, Paul R Fortin, Dafna D Gladman, Rosalind Ramsey-Goldman, John G Hanly, Murat Inanç, David Alan Isenberg, Anselm Mak, Marta Mosca, Michelle A Petri, Anisur Rahman, Jorge Sanchez-Guerrero, Murray B Urowitz, Daniel J Wallace, Sasha Bernatsky, Evelyne Vinet
Systemic Lupus Erythematosus Women with Lupus Nephritis in Pregnancy Therapeutic Challenge (SWITCH): The Systemic Lupus International Collaborating Clinics experience. Annals of the rheumatic diseases (2023)
Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, Martin Aringer, Laurent Arnaud, Sang-Cheol Bae, John Boletis, Ian N Bruce, Ricard Cervera, Andrea Doria, Thomas Dörner, Richard A Furie, Dafna D Gladman, Frederic A Houssiau, Luís Sousa Inês, David R W Jayne, Marios Kouloumas, László Kovács, Chi Chiu Mok, Eric F Morand, Gabriella Moroni, Marta Mosca, Johanna Mucke, Chetan B Mukhtyar, György Nagy, Sandra Navarra, Ioannis Parodis, José M Pego-Reigosa, Michelle A Petri, Bernardo A Pons-Estel, Matthias Schneider, Josef S Smolen, Elisabet Svenungsson, Yoshiya Tanaka, Maria G G Tektonidou, Y K Onno Teng, Angela Tincani, Edward M Vital, Ronald F Van Vollenhoven, Chris Wincup, George K Bertsias, Dimitrios T Boumpas
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Annals of the rheumatic diseases (2023)
Lars E Kristensen, Bruce E Strober, Denis Poddubnyy, Ying Ying Leung, Hyejin Jo, Kenneth Kwok, Ivana Vranic, Dona L Fleishaker, Lara Fallon, Arne Yndestad, Dafna D Gladman
Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib. Therapeutic advances in musculoskeletal disease 15 (2023)
Laura C Coates, Phillip J Mease, Dafna D Gladman, Sandra Navarra, Weibin Bao, Corine Gaillez
Secukinumab improves physical function and quality of life and inhibits structural damage in patients with PsA with sustained remission or low disease activity: results from the 2-year phase 3 FUTURE 5 study. RMD open 9 (2) (2023)
Vinod Chandran, Vladislav A Malkov, Kaori L Ito, Yihua Liu, Lene Vestergaard, Oh Kyu Yoon, Jinfeng Liu, Mona Trivedi, Angie Hertz, Dafna D Gladman
Pharmacodynamic effects of filgotinib treatment driving clinical improvement in patients with active psoriatic arthritis enrolled in the EQUATOR trial. RMD open 9 (4) (2023)
Robert Davies Inman, Denis Choquette, Majed Khraishi, Dafna D Gladman, Shamiza Hussein, Drew Neish, Patrick Leclerc
Real-world Retention and Clinical Effectiveness of Secukinumab for Axial Spondyloarthritis: Results From the Canadian Spondyloarthritis Research Network. The Journal of rheumatology (2023)
Laura C Coates, Phillip J Mease, Dafna D Gladman, Sandra Navarra, Weibin Bao, Corine Gaillez
Secukinumab improves physical function and quality of life and inhibits structural damage in patients with PsA with sustained remission or low disease activity: results from the 2-year phase 3 FUTURE 5 study. RMD open 9 (2) (2023)
May Yee Choi, Irene Chen, Ann Elaine Clarke, Marvin J Fritzler, Katherine A Buhler, Murray B Urowitz, John Hanly, Yvan St-Pierre, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Sasha Bernatsky, Daniel J Wallace, David Alan Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle A Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Graciela S Alarcon, Ronald F Van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sam Lim, Murat Inanç, Kenneth Kalunian, Søren Jacobsen, Christine Peschken, Diane L Kamen, Anca Askanase, Jill P Buyon, David Sontag, Karen H Costenbader
Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes. Annals of the rheumatic diseases (2023)
Beverly Cheok Kuan Ng, Deepak R Jadon, Frank Behrens, Maarten P T de Wit, Oliver M FitzGerald, Dafna D Gladman, Phillip J Mease, Denis O'Sullivan, Stephen R Pennington, Larissa Valor-Méndez, Vinod Chandran, Kurt de Vlam
Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual Meeting. The Journal of rheumatology (2023)
Laura Whittall-Garcia, Dafna D Gladman, Murray B Urowitz, Zahi Touma, Sindhu R Johnson
Correspondence on "relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus" by Chi Chiu Mok et al. Lupus 32 (6) (2023)
May Yee Choi, Irene Chen, Ann Elaine Clarke, Marvin J Fritzler, Katherine A Buhler, Murray B Urowitz, John Hanly, Yvan St-Pierre, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Sasha Bernatsky, Daniel J Wallace, David Alan Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle A Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Graciela S Alarcon, Ronald F Van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sam Lim, Murat Inanç, Kenneth Kalunian, Søren Jacobsen, Christine Peschken, Diane L Kamen, Anca Askanase, Jill P Buyon, David Sontag, Karen H Costenbader
Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes. Annals of the rheumatic diseases (2023)
Keith Colaco, Ker-Ai Lee, Shadi Akhtari, Raz Winer, Vinod Chandran, Paula Harvey, Richard J Cook, Vincent Piguet, Dafna D Gladman, Lihi Eder
Derivation and Internal Validation of a Disease-specific Cardiovascular Risk Prediction Model for Patients with Psoriatic Arthritis and Psoriasis. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Phillip J Mease, Dafna D Gladman, Denis Poddubnyy, Soumya D Chakravarty, May Shawi, Alexa P Kollmeier, Xie L Xu, Stephen Xu, Atul Deodhar, Xenofon Baraliakos
Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study. Rheumatology and therapy (2023)
Atul Deodhar, Dafna D Gladman, Rebecca Bolce, David Sandoval, So Young Park, Soyi Liu Leage, Peter Nash, Denis Poddubnyy
The effect of ixekizumab on axial manifestations in patients with psoriatic arthritis from two phase III clinical trials: SPIRIT-P1 and SPIRIT-P2. Therapeutic advances in musculoskeletal disease 15 (2023)
Ann Elaine Clarke, John G Hanly, Murray B Urowitz, Yvan St Pierre, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Sasha Bernatsky, Daniel J Wallace, David Alan Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle A Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Graciela S Alarcon, Ronald F Van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sung Sam Lim, Murat Inanc, Kenneth C Kalunian, Soren Jacobsen, Christine A Peschken, Diane L Kamen, Anca D Askanase, Vernon Farewell
Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics (SLICC) Cohort using Multistate Modelling. Arthritis care & research (2023)
Lihi Eder, Dafna D Gladman, Phillip J Mease, Remy A Pollock, Rayana Luna, Sibel Zehra Aydın, Alexis Ogdie, Ari Polachek, David Gruben, Mary Jane Cadatal, Cassandra Kinch, Vibeke Strand
Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension. RMD open 9 (1) (2023)
Ying Ying Leung, William Tillett, Maarten de Wit, Ana Maria Orbai, Laura C Coates, Oliver M FitzGerald, Philip S Helliwell, Vibeke Strand, Phillip J Mease, Niti Goel, Robin Christensen, Joseph Frank Merola, Christine A Lindsay, Philip S Helliwell, Laure Gossec, Dafna D Gladman
Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group. The Journal of rheumatology (2023)
Mohamad-Ali Rida, Ker-Ai Lee, Vinod Chandran, Richard J Cook, Dafna D Gladman
Persistence of Biologics in the Treatment of Psoriatic Arthritis (Psa): Data From a Large Hospital Based Longitudinal Cohort. Arthritis care & research (2023)
Laura C Coates, Phillip J Mease, Dafna D Gladman, Sandra Navarra, Weibin Bao, Corine Gaillez
Secukinumab improves physical function and quality of life and inhibits structural damage in patients with PsA with sustained remission or low disease activity: results from the 2-year phase 3 FUTURE 5 study. RMD open 9 (2) (2023)
Laura Whittall-Garcia, Dafna D Gladman, Murray B Urowitz, Zahi Touma, Sindhu R Johnson
Correspondence on "relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus" by Chi Chiu Mok et al. Lupus 32 (6) (2023)
Murat Torğutalp, Dafna D Gladman, Oliver M FitzGerald, Phillip J Mease, Denis Poddubnyy
Project Highlights From the GRAPPA 2022 Annual Meeting: Education Initiatives and Axial Involvement in Psoriatic Arthritis. The Journal of rheumatology (2023)
Beverly Cheok Kuan Ng, Deepak R Jadon, Adewale O Adebajo, Gizem Ayan, Kristina Callis Duffin, Vinod Chandran, Laura C Coates, Maria Antonietta D'Agostino, Kurt de Vlam, Atul A Deodhar, Lihi Eder, Amit Garg, Dafna D Gladman, Niti Goel, Alice B Gottlieb, M Elaine Husni, Arnon M Katz, Arthur Kavanaugh, Ennio Lubrano, Phillip J Mease, Joseph Frank Merola, Peter Nash, Philip S Helliwell, Stephen R Pennington, Lourdes Maria Perez-Chada, Fabian Proft, Cheryl F Rosen, Laura Savage, Cláudia Goldenstein-Schainberg, Stefan Siebert, Enrique Roberto Soriano, Ingrid Steinkoenig, William Tillett, April W Armstrong, Oliver M FitzGerald
Proceedings of the GRAPPA 2022 Executive Retreat. The Journal of rheumatology (2023)
Alice B Gottlieb, April W Armstrong, Oliver M FitzGerald, Dafna D Gladman
Prologue: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 Annual Meeting. The Journal of rheumatology (2023)
Kieran Manion, Carolina Muñoz-Grajales, Michael Kim, Atenafu G Eshetu, Zoha Faheem, Dafna D Gladman, Murray Urowitz, Zahi Touma, Joan E Wither
Different Immunologic Profiles are Associated with Distinct Clinical Phenotypes in Longitudinally Followed Systemic Lupus Erythematosus Patients. Arthritis & rheumatology (Hoboken, N.J.) (2023)
May Yee Choi, Irene Chen, Ann Elaine Clarke, Marvin J Fritzler, Katherine A Buhler, Murray B Urowitz, John Hanly, Yvan St-Pierre, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Sasha Bernatsky, Daniel J Wallace, David Alan Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle A Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Graciela S Alarcon, Ronald F Van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sam Lim, Murat Inanç, Kenneth Kalunian, Søren Jacobsen, Christine Peschken, Diane L Kamen, Anca Askanase, Jill P Buyon, David Sontag, Karen H Costenbader
Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes. Annals of the rheumatic diseases (2023)
Omar F Cruz-Correa, Remy A Pollock, Rohan Machhar, Dafna D Gladman
PREDICTION OF PSORIATIC ARTHRITIS IN PATIENTS WITH PSORIASIS USING DNA METHYLATION PROFILES. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Yann Nguyen, Benoît Blanchet, Murray B Urowitz, John G Hanly, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Ann Elaine Clarke, Sasha Bernatsky, Daniel J Wallace, David Alan Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle A Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Graciela S Alarcon, Ronald F van Vollenhoven, Cynthia Aranow, Véronique Le Guern, Meggan Mackay, Guillermo Ruiz-Irastorza, Sung Sam Lim, Murat Inanc, Kenneth C Kalunian, Søren Jacobsen, Christine A Peschken, Diane L Kamen, Anca D Askanase, Jill Buyon, Nathalie Costedoat-Chalumeau
Association between severe non-adherence to hydroxychloroquine and SLE flares, damage, and mortality in 660 patients from the SLICC Inception Cohort. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Laura Whittall-Garcia, Dafna D Gladman, Murray B Urowitz, Zahi Touma, Sindhu R Johnson
Correspondence on "relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus" by Chi Chiu Mok et al. Lupus (2023)
Laura C Coates, Phillip J Mease, Dafna D Gladman, Sandra Navarra, Weibin Bao, Corine Gaillez
Secukinumab improves physical function and quality of life and inhibits structural damage in patients with PsA with sustained remission or low disease activity: results from the 2-year phase 3 FUTURE 5 study. RMD open 9 (2) (2023)
May Yee Choi, Irene Chen, Ann Elaine Clarke, Marvin J Fritzler, Katherine A Buhler, Murray B Urowitz, John Hanly, Yvan St-Pierre, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Sasha Bernatsky, Daniel J Wallace, David Alan Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle A Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Graciela S Alarcon, Ronald F Van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sam Lim, Murat Inanç, Kenneth Kalunian, Søren Jacobsen, Christine Peschken, Diane L Kamen, Anca Askanase, Jill P Buyon, David Sontag, Karen H Costenbader
Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes. Annals of the rheumatic diseases (2023)
Lars E Kristensen, Bruce E Strober, Denis Poddubnyy, Ying Ying Leung, Hyejin Jo, Kenneth Kwok, Ivana Vranic, Dona L Fleishaker, Lara Fallon, Arne Yndestad, Dafna D Gladman
Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib. Therapeutic advances in musculoskeletal disease 15 (2023)
Ann Elaine Clarke, John G Hanly, Murray B Urowitz, Yvan St Pierre, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Sasha Bernatsky, Daniel J Wallace, David Alan Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle A Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Graciela S Alarcon, Ronald F Van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sung Sam Lim, Murat Inanc, Kenneth C Kalunian, Soren Jacobsen, Christine A Peschken, Diane L Kamen, Anca D Askanase, Vernon Farewell
Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics Cohort Using Multistate Modeling. Arthritis care & research (2023)
Lihi Eder, Ker-Ai Lee, Vinod Chandran, Jessica Widdifield, Aaron M Drucker, Christopher T Ritchlin, Cheryl F Rosen, Richard J Cook, Dafna D Gladman
Derivation of a multivariable psoriatic arthritis risk estimation tool (PRESTO): a step towards prevention. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Dafna D Gladman, Phillip J Mease, Paul Bird, Enrique Roberto Soriano, Soumya D Chakravarty, May Shawi, Frederic Lavie, Cinty Gong, Evan Leibowitz, Denis Poddubnyy, Lai Shan Tam, Philip S Helliwell, Arthur Kavanaugh, Atul A Deodhar, Mikkel Østergaard, Xenofon Baraliakos
Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?' by Braun and Landewé. Annals of the rheumatic diseases (2022)
Dafna D Gladman, Philip J Mease, Paul Bird, Enrique Roberto Soriano, Soumya D Chakravarty, May Shawi, Stephen Xu, Sean T Quinn, Cinty Gong, Evan Leibowitz, Denis Poddubnyy, Lai-Shan Tam, Philip S Helliwell, Arthur Kavanaugh, Atul Deodhar, Mikkel Østergaard, Xenofon Baraliakos
Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial. Trials 23 (1) (2022)
Laura C Coates, Enrique R Soriano, Nadia Corp, Heidi Bertheussen, Kristina Callis Duffin, Cristiano B Campanholo, Jeffrey Chau, Lihi Eder, Daniel G Fernández-Ávila, Oliver M FitzGerald, Amit Garg, Dafna D Gladman, Niti Goel, Philip S Helliwell, M Elaine Husni, Deepak R Jadon, Arnon Katz, Dhruvkumar Laheru, John Latella, Ying Ying Leung, Christine A Lindsay, Ennio Lubrano, Luis Daniel Mazzuoccolo, Phillip J Mease, Denis O'Sullivan, Alexis Ogdie, Wendy Olsder, Penelope Esther Palominos, Lori Schick, Ingrid Steinkoenig, Maarten P T de Wit, D A van der Windt, Arthur Kavanaugh, null null
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nature reviews. Rheumatology 18 (8) (2022)
Kristina Callis Duffin, Dafna D Gladman, Niti Goel, Alice B Gottlieb, Oliver M FitzGerald, Lynne V McFarland
Prologue: 2021 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The Journal of rheumatology 49 (6 Suppl 1) (2022)
Dafna D Gladman, Denis Choquette, Majed Khraishi, Robert Davies Inman, Shamiza Hussein, Drew Neish, Patrick Leclerc
Real-World Retention and Clinical Effectiveness of Secukinumab for Psoriatic Arthritis: Results From the Canadian Spondyloarthritis Research Network. The Journal of rheumatology (2022)
Dafna D Gladman
Sex Effect in Psoriatic Arthritis. The Journal of rheumatology (2022)
Ennio Lubrano, Jonathan Chan, Rubén Queiro, Alberto Cauli, Niti Goel, Denis Poddubnyy, Peter Nash, Dafna D Gladman
Management of Axial Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. The Journal of rheumatology (2022)
Seiwon Park, Orli M Silverberg, Elham Moez, Vinod Chandran, Dafna D Gladman
Investigation into the wait time for consultation in the psoriatic arthritis program. Clinical rheumatology 41 (12) (2022)
Manuel Francisco Ugarte-Gil, John Hanly, Murray B Urowitz, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Sasha Bernatsky, Ann Elaine Clarke, Daniel J Wallace, David Alan Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle A Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Ronald F Van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sam Lim, Murat Inanç, Ken Kalunian, Søren Jacobsen, Christine Peschken, Diane L Kamen, Anca Askanase, Bernardo A Pons-Estel, Graciela S Alarcon
Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. Annals of the rheumatic diseases 81 (11) (2022)
Dafna D Gladman, Laura C Coates, Joseph Wu, Lara Fallon, Elizabeth D Bacci, Joseph C Cappelleri, Andrew G Bushmakin, Philip S Helliwell
Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo. Arthritis research & therapy 24 (1) (2022)
May Yee Choi, Ann Elaine Clarke, Murray B Urowitz, John Hanly, Yvan St-Pierre, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Sasha Bernatsky, Daniel J Wallace, David Alan Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle A Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Graciela S Alarcon, Ronald F Van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sam Lim, Murat Inanç, Ken Kalunian, Søren Jacobsen, Christine Peschken, Diane L Kamen, Anca Askanase, Jill P Buyon, Karen H Costenbader, Marvin J Fritzler
Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort. Annals of the rheumatic diseases 81 (8) (2022)
Anika Lucas, Amanda M Eudy, Dafna D Gladman, Michelle A Petri, Murray B Urowitz, Christina M Wyatt, Megan Eb Clowse
The association of lupus nephritis with adverse pregnancy outcomes among women with lupus in North America. Lupus 31 (11) (2022)
Phillip J Mease, Arthur Kavanaugh, Philip S Helliwell, Alvin F Wells, Martin Bergman, Dafna D Gladman, Sven Richter, Lichen Teng, Shauna Jardon, Josef S Smolen
Baseline Disease Activity Predicts Achievement of cDAPSA Treatment Targets With Apremilast: Phase III Results in DMARD-naïve Patients With Psoriatic Arthritis. The Journal of rheumatology 49 (7) (2022)
Philip S Helliwell, Phillip J Mease, Arthur Kavanaugh, Laura C Coates, Philip S Helliwell, Atul Deodhar, Vibeke Strand, Gregory Kricorian, Lyrica X H Liu, David Collier, Dafna D Gladman
Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial. RMD open 8 (2) (2022)
Anna S Antony, Richard Holland, Ashish J Mathew, Maria Antonietta D'Agostino, Walter P Maksymowych, Phillip J Mease, Niti Goel, Philip S Helliwell, Laura C Coates, Vibeke Strand, Robin Christensen, Dafna D Gladman, Ana Maria Orbai, Ying Ying Leung, William Tillett
Plain Radiographic Instruments for Structural Damage in Peripheral Joints in Psoriatic Arthritis: A Report From the GRAPPA-OMERACT Working Group. The Journal of rheumatology 49 (6 Suppl 1) (2022)
Phillip J Mease, Dafna D Gladman, Joseph Frank Merola, Atul Deodhar, Philip S Helliwell, David H Collier, Lyrica Liu, Arthur Kavanaugh
Potential Impact of Sex and BMI on Response to Therapy in Psoriatic Arthritis: Post Hoc Analysis of Results From the SEAM-PsA Trial. The Journal of rheumatology 49 (8) (2022)
Timothy S H Kwok, Mitchell Sutton, Daniel Pereira, Richard J Cook, Vinod Chandran, Nigil Haroon, Robert D Inman, Dafna D Gladman
Isolated axial disease in psoriatic arthritis and ankylosing spondylitis with psoriasis. Annals of the rheumatic diseases 81 (12) (2022)
Ashish J Mathew, Mitchell Sutton, Daniel Pereira, Dafna D Gladman, Vinod Chandran
Effectiveness of Disease-Modifying Antirheumatic Drugs for Enthesitis in a Prospective Longitudinal Psoriatic Arthritis Cohort. The Journal of rheumatology 49 (9) (2022)
Keith Colaco, Ker-Ai Lee, Shadi Akhtari, Raz Winer, Paul I Welsh, Naveed Sattar, Iain B McInnes, Vinod Chandran, Paula Harvey, Richard J Cook, Dafna D Gladman, Vincent Piguet, Lihi Eder
Association of Cardiac Biomarkers With Cardiovascular Outcomes in Patients With Psoriatic Arthritis and Psoriasis: A Longitudinal Cohort Study. Arthritis & rheumatology (Hoboken, N.J.) 74 (7) (2022)
Nouf A Alhammadi, Dafna D Gladman, Jiandong Su, Murray B Urowitz
Isolated Neutropenia in Systemic Lupus Erythematosus. The Journal of rheumatology (2022)
Konstantinos Tselios, Dafna D Gladman, Jiandong Su, Murray B Urowitz
Gradual Glucocorticosteroid Withdrawal Is Safe in Clinically Quiescent Systemic Lupus Erythematosus. ACR open rheumatology 3 (8) (2021)
Antonio Wong, Justine Y Ye, Richard J Cook, Dafna D Gladman, Vinod Chandran
Depression and Anxiety Reduce the Probability of Achieving a State of Sustained Minimal Disease Activity in Patients with Psoriatic Arthritis. Arthritis care & research (2021)
Dafna D Gladman, Justine Y Ye, Vinod Chandran, Ker-Ai Lee, Richard J Cook
Oligoarticular vs Polyarticular Psoriatic Arthritis: A Longitudinal Study Showing Similar Characteristics. The Journal of rheumatology 48 (12) (2021)
Ying Ying Leung, William Tillett, Pil Højgaard, Ana Maria Orbai, Richard Holland, Ashish J Mathew, Niti Goel, Jeffrey Chau, Christine A Lindsay, Philip S Helliwell, Laura C Coates, Robin Christensen, Philip J Mease, Vibeke Strand, Dafna D Gladman
Test-retest Reliability for HAQ-DI and SF-36 PF for the Measurement of Physical Function in Psoriatic Arthritis. The Journal of rheumatology 48 (10) (2021)
Keith Colaco, Ker-Ai Lee, Shadi Akhtari, Raz Winer, Paul Welsh, Naveed Sattar, Iain B McInnes, Vinod Chandran, Paula Harvey, Richard J Cook, Dafna D Gladman, Vincent Piguet, Lihi Eder
Targeted metabolomic profiling and prediction of cardiovascular events: a prospective study of patients with psoriatic arthritis and psoriasis. Annals of the rheumatic diseases 80 (11) (2021)

Dafna D Gladman.css-eqlu8i{font-size:small;padding-left:4px;} (D D Gladman, Dafna Gladman)

Publication Activity (10 Years)

Top Topics

Top Venues

Dafna D Gladman (D D Gladman, Dafna Gladman)